3/25
08:03 am
jbio
Jade Biosciences (JBIO) had its price target raised by HC Wainwright from $25.00 to $35.00. They now have a "buy" rating on the stock.
Medium
Report
Jade Biosciences (JBIO) had its price target raised by HC Wainwright from $25.00 to $35.00. They now have a "buy" rating on the stock.
3/16
08:03 am
jbio
Jade Biosciences (JBIO) had its price target raised by BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
Medium
Report
Jade Biosciences (JBIO) had its price target raised by BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
3/12
06:32 am
jbio
Jade Biosciences (JBIO) was downgraded by Zacks Research from "hold" to "strong sell".
Medium
Report
Jade Biosciences (JBIO) was downgraded by Zacks Research from "hold" to "strong sell".
3/11
08:03 am
jbio
Jade Biosciences (JBIO) had its price target raised by Guggenheim from $17.00 to $23.00. They now have a "buy" rating on the stock.
Medium
Report
Jade Biosciences (JBIO) had its price target raised by Guggenheim from $17.00 to $23.00. They now have a "buy" rating on the stock.
3/10
06:21 am
jbio
Jade Biosciences (JBIO) was upgraded by William Blair to "strong-buy".
Low
Report
Jade Biosciences (JBIO) was upgraded by William Blair to "strong-buy".
3/9
08:43 am
jbio
Jade Biosciences (JBIO) had its "outperform" rating reaffirmed by Wedbush. They now have a $24.00 price target on the stock.
Medium
Report
Jade Biosciences (JBIO) had its "outperform" rating reaffirmed by Wedbush. They now have a $24.00 price target on the stock.
3/7
05:30 am
jbio
Jade Biosciences (JBIO) was upgraded by Lifesci Capital to "strong-buy".
Low
Report
Jade Biosciences (JBIO) was upgraded by Lifesci Capital to "strong-buy".
3/6
03:03 pm
jbio
Jade Biosciences (JBIO) was given a new $40.00 price target by Stifel Nicolaus.
Low
Report
Jade Biosciences (JBIO) was given a new $40.00 price target by Stifel Nicolaus.
3/6
02:18 pm
jbio
Jade Biosciences, Inc. reports Q4 results [Seeking Alpha]
Low
Report
Jade Biosciences, Inc. reports Q4 results [Seeking Alpha]
3/6
07:32 am
jbio
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/6
07:00 am
jbio
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Low
Report
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
2/28
11:57 am
jbio
Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears [Yahoo! Finance]
Medium
Report
Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears [Yahoo! Finance]
2/27
05:38 pm
jbio
Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript [Seeking Alpha]
Medium
Report
Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript [Seeking Alpha]
2/11
07:31 am
jbio
Jade Biosciences to Participate in Upcoming Conferences [Yahoo! Finance]
Low
Report
Jade Biosciences to Participate in Upcoming Conferences [Yahoo! Finance]
2/11
07:00 am
jbio
Jade Biosciences to Participate in Upcoming Conferences
Low
Report
Jade Biosciences to Participate in Upcoming Conferences
1/19
08:12 am
jbio
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue [Yahoo! Finance]
Medium
Report
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue [Yahoo! Finance]
1/8
06:15 am
jbio
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
1/7
07:18 am
jbio
Jade Biosciences (NASDAQ:JBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Low
Report
Jade Biosciences (NASDAQ:JBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
1/6
08:27 am
jbio
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week [Yahoo! Finance]
Low
Report
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week [Yahoo! Finance]
1/5
07:19 am
jbio
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:00 am
jbio
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference